These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36252994)

  • 21. Characteristics and lipid lowering treatment patterns in patients tested for lipoprotein(a): A real-world US study.
    Hu X; Cristino J; Gautam R; Mehta R; Amari D; Heo JH; Wang S; Wong ND
    Am J Prev Cardiol; 2023 Jun; 14():100476. PubMed ID: 36936405
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single Ascending Dose Study of a Short Interfering RNA Targeting Lipoprotein(a) Production in Individuals With Elevated Plasma Lipoprotein(a) Levels.
    Nissen SE; Wolski K; Balog C; Swerdlow DI; Scrimgeour AC; Rambaran C; Wilson RJ; Boyce M; Ray KK; Cho L; Watts GF; Koren M; Turner T; Stroes ES; Melgaard C; Campion GV
    JAMA; 2022 May; 327(17):1679-1687. PubMed ID: 35368052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Family history of early cardiovascular disease in children with moderate to severe hypercholesterolemia: relationship to lipoprotein (a) and low-density lipoprotein cholesterol levels.
    Barth JA; Deckelbaum RJ; Starc TJ; Shea S; Mosca L; Berglund L
    J Lab Clin Med; 1999 Mar; 133(3):237-44. PubMed ID: 10072255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The correlation between lipoprotein(a) and coronary atherosclerotic lesion is stronger than LDL-C, when LDL-C is less than 104 mg/dL.
    Li C; Chen Q; Zhang M; Liu Y; Chu Y; Meng F; Wang J; Tang J; Luo J; Niu X; Wei M
    BMC Cardiovasc Disord; 2021 Jan; 21(1):41. PubMed ID: 33468066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incremental Benefit of Lipid Lowering in a Large Chinese Population Aged 75 Years and Older With Established Atherosclerotic Cardiovascular Disease.
    Lin Z; Chen Y; Xiao Z; Xu W; Chen G; Huang C; Feng W; Xie Z; Liao W; Liao Y; Bin J; Feng L; Wang S
    Mayo Clin Proc; 2023 Sep; 98(9):1280-1296. PubMed ID: 37661139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Rikhi R; Hammoud A; Ashburn N; Snavely AC; Michos ED; Chevli P; Tsai MY; Herrington D; Shapiro MD
    Atherosclerosis; 2022 Dec; 363():102-108. PubMed ID: 36253168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipoprotein(a) and mortality-a high risk relationship.
    Klingel R; Heibges A; Fassbender C
    Clin Res Cardiol Suppl; 2019 Apr; 14(Suppl 1):13-19. PubMed ID: 30838554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between lipoprotein(a) concentrations and atherosclerotic cardiovascular disease risk in patients with familial hypercholesterolemia: an analysis from the HELLAS-FH.
    Anagnostis P; Rizos CV; Skoumas I; Rallidis L; Tziomalos K; Skalidis E; Kotsis V; Doumas M; Kolovou G; Sfikas G; Garoufi A; Lambadiari V; Dima I; Kiouri E; Agapakis D; Zacharis E; Antza C; Kolovou V; Koumaras C; Bantouvakis G; Liamis G; Liberopoulos EN
    Endocrine; 2022 May; 76(2):324-330. PubMed ID: 35262845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of C-Reactive Protein on Lipoprotein(a)-Associated Cardiovascular Risk in Optimally Treated Patients With High-Risk Vascular Disease: A Prespecified Secondary Analysis of the ACCELERATE Trial.
    Puri R; Nissen SE; Arsenault BJ; St John J; Riesmeyer JS; Ruotolo G; McErlean E; Menon V; Cho L; Wolski K; Lincoff AM; Nicholls SJ
    JAMA Cardiol; 2020 Oct; 5(10):1136-1143. PubMed ID: 32639518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.
    Puri R; Ballantyne CM; Hoogeveen RC; Shao M; Barter P; Libby P; Chapman MJ; Erbel R; Arsenault BJ; Raichlen JS; Nissen SE; Nicholls SJ
    Atherosclerosis; 2017 Aug; 263():137-144. PubMed ID: 28641153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low-Density Lipoprotein Cholesterol Is Predominantly Associated With Atherosclerotic Cardiovascular Disease Events in Patients With Evidence of Coronary Atherosclerosis: The Western Denmark Heart Registry.
    Mortensen MB; Dzaye O; Bøtker HE; Jensen JM; Maeng M; Bentzon JF; Kanstrup H; Sørensen HT; Leipsic J; Blankstein R; Nasir K; Blaha MJ; Nørgaard BL
    Circulation; 2023 Apr; 147(14):1053-1063. PubMed ID: 36621817
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein(a) and Long-Term Cardiovascular Risk in a Multi-Ethnic Pooled Prospective Cohort.
    Wong ND; Fan W; Hu X; Ballantyne C; Hoodgeveen RC; Tsai MY; Browne A; Budoff MJ
    J Am Coll Cardiol; 2024 Apr; 83(16):1511-1525. PubMed ID: 38631771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of lowering elevated LDL cholesterol on the cardiovascular risk of lipoprotein(a).
    Maher VM; Brown BG; Marcovina SM; Hillger LA; Zhao XQ; Albers JJ
    JAMA; 1995 Dec; 274(22):1771-4. PubMed ID: 7500507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk.
    O'Donoghue ML; Fazio S; Giugliano RP; Stroes ESG; Kanevsky E; Gouni-Berthold I; Im K; Lira Pineda A; Wasserman SM; Češka R; Ezhov MV; Jukema JW; Jensen HK; Tokgözoğlu SL; Mach F; Huber K; Sever PS; Keech AC; Pedersen TR; Sabatine MS
    Circulation; 2019 Mar; 139(12):1483-1492. PubMed ID: 30586750
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipoprotein(a)-Lowering by 50 mg/dL (105 nmol/L) May Be Needed to Reduce Cardiovascular Disease 20% in Secondary Prevention: A Population-Based Study.
    Madsen CM; Kamstrup PR; Langsted A; Varbo A; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):255-266. PubMed ID: 31578080
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study.
    Longenecker JC; Coresh J; Marcovina SM; Powe NR; Levey AS; Giaculli F; Fink NE; Klag MJ
    Am J Kidney Dis; 2003 Jul; 42(1):108-16. PubMed ID: 12830462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lp(a) (Lipoprotein(a)) Levels Predict Progression of Carotid Atherosclerosis in Subjects With Atherosclerotic Cardiovascular Disease on Intensive Lipid Therapy: An Analysis of the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Carotid Magnetic Resonance Imaging Substudy-Brief Report.
    Hippe DS; Phan BAP; Sun J; Isquith DA; O'Brien KD; Crouse JR; Anderson T; Huston J; Marcovina SM; Hatsukami TS; Yuan C; Zhao XQ
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):673-678. PubMed ID: 29301785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of Lipoprotein(a) on Stroke Recurrence Attenuates at Low LDL-C (Low-Density Lipoprotein) and Inflammation Levels.
    Xu J; Hao X; Zhan R; Jiang X; Jin A; Xue J; Cheng A; Liu J; Lin J; Meng X; Li H; Zheng L; Wang Y
    Stroke; 2022 Aug; 53(8):2504-2511. PubMed ID: 35410491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic value of elevated lipoprotein(a) in patients with acute coronary syndromes.
    Gencer B; Rigamonti F; Nanchen D; Vuilleumier N; Kern I; Aghlmandi S; Klingenberg R; Räber L; Auer R; Carballo D; Carballo S; Heg D; Windecker S; Lüscher TF; Matter CM; Rodondi N; Mach F
    Eur J Clin Invest; 2019 Jul; 49(7):e13117. PubMed ID: 30937890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of LPA Variants With Risk of Coronary Disease and the Implications for Lipoprotein(a)-Lowering Therapies: A Mendelian Randomization Analysis.
    Burgess S; Ference BA; Staley JR; Freitag DF; Mason AM; Nielsen SF; Willeit P; Young R; Surendran P; Karthikeyan S; Bolton TR; Peters JE; Kamstrup PR; Tybjærg-Hansen A; Benn M; Langsted A; Schnohr P; Vedel-Krogh S; Kobylecki CJ; Ford I; Packard C; Trompet S; Jukema JW; Sattar N; Di Angelantonio E; Saleheen D; Howson JMM; Nordestgaard BG; Butterworth AS; Danesh J;
    JAMA Cardiol; 2018 Jul; 3(7):619-627. PubMed ID: 29926099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.